Because lymphopenia is often found in advanced HIV-associated immunodeficiency [47], a normalized input of PBMC used in ELISPOT assays may partly explain why this assay appears to retain its efficiency among patients with low CD4+ cell counts. Here, CD4 is linked to immune system disorder.